In an interview with CNBC, Albert Burla added that if clinical trials went well and the Food and Drug Administration approved the drug, it could be distributed in the United States by the end of the year.
Health experts say the drug, which is taken orally when symptoms appear, can change the rules of the game, because people with the new virus can use it outside of hospitals.
And Pfizer, which developed with the German pharmaceutical company Biontech, the first vaccine against Covid-19 licensed for use in the United States, began an initial phase of clinical trials in March to try a new antiviral treatment to counteract it. the Covid-19.
The drug, which is part of the class of “protease inhibitors”, works by inhibiting an enzyme that the virus needs to multiply in human cells, and is a technique used to treat other viral diseases, such as Acquired immunodeficiency, “AIDS,” and viral hepatitis C.
Although the initial efficacy test focuses on the initial stage of infection in people, “Pfizer” also plans to explore whether the drug works to protect healthy people who have been exposed to the Crown virus, such as members of the family or roommates living with an infected person. person.
Vaccine Pfizer Kids
Pfizer is still testing its vaccine in children between the ages of 6 months and 11, and public health officials and infectious disease experts say vaccinating children is critical to ending the coronavirus pandemic.
And earlier this month, the company asked the U.S. Food and Drug Administration (FDA) to extend the vaccine’s license to allow teens between the ages of 12 and 15 to use it.
During his interview with CNBC, Burla expressed his optimism that the U.S. Food and Drug Administration would approve the use of the vaccine to vaccinate teens.